Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_assertion type Assertion NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_head.
- NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_assertion description "[We studied nine patients affected by chronic myeloid leukemia (CML Ph+ and bcr-abl positive) and treated with alpha-interferon (alpha-INF) in order to: first, to evaluate the feasibility of a mobilization of peripheral blood stem cells induced by granulocyte-colony-stimulating factor (G-CSF) and the contamination by Ph+ cells and second, to quantify the amount of bcr-abl leukemia associated transcript by a quantitative assay during mobilization procedures, and post mobilization follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_provenance.
- NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_assertion evidence source_evidence_literature NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_provenance.
- NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_assertion SIO_000772 10975389 NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_provenance.
- NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_assertion wasDerivedFrom befree-2016 NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_provenance.
- NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_assertion wasGeneratedBy ECO_0000203 NP294307.RA-2HTsFGFHJTYU_eDy6TfvYt6XYp-Kxh9QB5EHMM_wrU130_provenance.